norethindrone has been researched along with hrp 112 in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 15 (68.18) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Sayed, WS; Darwish, EA; el-Habashy, MA; Haiba, NA; Nayel, SE; Said, SA | 1 |
| Aedo, AR; Diczfalusy, E; Johannisson, E; Landgren, BM | 1 |
| Chen, JK; Chen, SF; Fang, KJ; Ge, JL; Ge, RS; He, ML; Luo, SY; Sang, GW; Shao, QX; Song, S | 2 |
| Bassol, S; Hernandez, C; Luz de la Cruz, D; Nava, MP; Trujillo, AM | 1 |
| Toppozada, MK | 1 |
| Sang, GW | 1 |
| Koetsawang, S | 1 |
| el-Hussein, M; el-Nahal, N; Hassan, EO | 1 |
| d'Arcangues, C | 1 |
| el Houssinie, M; el Nahal, N; Hassan, EO | 1 |
| el-Hussinie, M; el-Nahal, N; Hassan, EO | 1 |
| Cromie, MA; Garceau, RJ; Kaunitz, AM | 1 |
| Oleen-Burkey, M; Shulman, LP; Willke, RJ | 1 |
| Cromie, MA; Maile, MH; Wajszczuk, CP | 1 |
| Garceau, RJ; Kaunitz, AM; Wajszczuk, CJ | 1 |
| Bassol, S; Canto de Cetina, TE; Cetina Canto, JA; Luna, MO | 1 |
4 review(s) available for norethindrone and hrp 112
| Article | Year |
|---|---|
Existing once-a-month combined injectable contraceptives.
Topics: Algestone Acetophenide; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Latin America; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1994 |
Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Estradiol; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; World Health Organization | 1993 |
15 trial(s) available for norethindrone and hrp 112
| Article | Year |
|---|---|
Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone | 1989 |
A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. II. The comparison of bleeding patterns. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility
Topics: Amenorrhea; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1989 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Patient Dropouts | 1995 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone | 1995 |
A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estrone; Female; Glucuronates; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Mexico; Norethindrone; Ovulation; Pregnanediol | 1995 |
Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
Topics: Attitude; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Egypt; Estradiol; Female; Humans; Marriage; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Retrospective Studies; Surveys and Questionnaires | 1994 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank,
Topics: Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Injections; Lipids; Lipoproteins; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Triglycerides | 1997 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Sp
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; gamma-Glutamyltransferase; Glucose Tolerance Test; Humans; Injections; Liver; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone | 1998 |
Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Egypt; Estradiol; Female; Humans; Injections, Intravenous; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Weight Gain | 1999 |
Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lu
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Metrorrhagia; Norethindrone; Patient Compliance; Pregnancy; Weight Gain | 1999 |
Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Patient Satisfaction; Surveys and Questionnaires | 1999 |
Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigator
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Lipids; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Triglycerides | 2000 |
Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Patient Compliance; Uterine Hemorrhage | 2000 |
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin | 2003 |
Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
Topics: Adolescent; Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Norethindrone | 2004 |
3 other study(ies) available for norethindrone and hrp 112
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Endometrium; Estradiol; Female; Humans; Injections; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Ovulation; Progesterone | 1985 |
Once-a-month injectable contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1993 |
Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Counseling; Drug Combinations; Egypt; Estradiol; Female; Focus Groups; Humans; Islam; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Social Support | 1999 |